APO Research

APO RESEARCH · REPORT

Defibrinated Horse Blood

Selected research

Market Analysis & Forecast

Global Defibrinated Horse Blood Market Analysis and Forecast 2026-2032

Market perspective

The global Defibrinated Horse Blood market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Defibrinated Horse Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Defibrinated Horse Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Defibrinated Horse Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Defibrinated Horse Blood is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Defibrinated Horse Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Biowest(BioNordic A/S), Pel-Freez Biologicals, Trafalgar Scientific and HemoStat Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Defibrinated Horse Blood, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Defibrinated Horse Blood, also provides the sales of main regions and countries. Of the upcoming market potential for Defibrinated Horse Blood, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Defibrinated Horse Blood sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Defibrinated Horse Blood market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Defibrinated Horse Blood sales, projected growth trends, production technology, application and end-user industry.

Defibrinated Horse Blood Segment by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Biowest(BioNordic A/S)

Pel-Freez Biologicals

Trafalgar Scientific

HemoStat Laboratories

EWC Diagnostics

Dutscher

Serana Europe

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Defibrinated Horse Blood Segment by Type

50ml

100ml

250ml

500ml

Others

Defibrinated Horse Blood Segment by Application

Biomedicine

Research

Defibrinated Horse Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Horse Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Horse Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Horse Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Defibrinated Horse Blood in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Defibrinated Horse Blood manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Defibrinated Horse Blood sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Defibrinated Horse Blood Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50ml Major Manufacturers Table 3. 100ml Major Manufacturers Table 4. 250ml Major Manufacturers Table 5. 500ml Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Defibrinated Horse Blood Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Biomedicine Major Manufacturers Table 9. Research Major Manufacturers Table 10. Defibrinated Horse Blood Industry Trends Table 11. Defibrinated Horse Blood Industry Drivers Table 12. Defibrinated Horse Blood Industry Opportunities and Challenges Table 13. Defibrinated Horse Blood Industry Restraints Table 14. Global Defibrinated Horse Blood Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Defibrinated Horse Blood Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Defibrinated Horse Blood Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Defibrinated Horse Blood Revenue Market Share by Region (2021-2026) Table 18. Global Defibrinated Horse Blood Revenue Market Share by Region (2027-2032) Table 19. Global Defibrinated Horse Blood Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kL) Table 20. Global Defibrinated Horse Blood Sales by Region (2021-2026) & (kL) Table 21. Global Defibrinated Horse Blood Sales by Region (2027-2032) & (kL) Table 22. Global Defibrinated Horse Blood Sales Market Share by Region (2021-2026) Table 23. Global Defibrinated Horse Blood Sales Market Share by Region (2027-2032) Table 24. Global Defibrinated Horse Blood Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Defibrinated Horse Blood Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Defibrinated Horse Blood Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Defibrinated Horse Blood Sales Market Share by Manufacturers (2021-2026) Table 28. Global Defibrinated Horse Blood Sales Price (USD/L) of Manufacturers (2021-2026) Table 29. Global Defibrinated Horse Blood Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Defibrinated Horse Blood Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Defibrinated Horse Blood Manufacturers, Product Type & Application Table 32. Global Defibrinated Horse Blood Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Defibrinated Horse Blood by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Defibrinated Horse Blood Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Defibrinated Horse Blood Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Defibrinated Horse Blood Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Defibrinated Horse Blood Revenue Market Share by Type (2021-2026) Table 39. Global Defibrinated Horse Blood Revenue Market Share by Type (2027-2032) Table 40. Global Defibrinated Horse Blood Sales by Type 2021 VS 2025 VS 2032 (kL) Table 41. Global Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 42. Global Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 43. Global Defibrinated Horse Blood Sales Market Share by Type (2021-2026) Table 44. Global Defibrinated Horse Blood Sales Market Share by Type (2027-2032) Table 45. Global Defibrinated Horse Blood Price by Type (2021-2026) & (USD/L) Table 46. Global Defibrinated Horse Blood Price by Type (2027-2032) & (USD/L) Table 47. Global Defibrinated Horse Blood Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Defibrinated Horse Blood Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Defibrinated Horse Blood Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Defibrinated Horse Blood Revenue Market Share by Application (2021-2026) Table 51. Global Defibrinated Horse Blood Revenue Market Share by Application (2027-2032) Table 52. Global Defibrinated Horse Blood Sales by Application 2021 VS 2025 VS 2032 (kL) Table 53. Global Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 54. Global Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 55. Global Defibrinated Horse Blood Sales Market Share by Application (2021-2026) Table 56. Global Defibrinated Horse Blood Sales Market Share by Application (2027-2032) Table 57. Global Defibrinated Horse Blood Price by Application (2021-2026) & (USD/L) Table 58. Global Defibrinated Horse Blood Price by Application (2027-2032) & (USD/L) Table 59. Thermo Fisher Scientific Company Information Table 60. Thermo Fisher Scientific Business Overview Table 61. Thermo Fisher Scientific Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 62. Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio Table 63. Thermo Fisher Scientific Recent Development Table 64. TCS Biosciences Company Information Table 65. TCS Biosciences Business Overview Table 66. TCS Biosciences Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 67. TCS Biosciences Defibrinated Horse Blood Product Portfolio Table 68. TCS Biosciences Recent Development Table 69. BioMérieux Company Information Table 70. BioMérieux Business Overview Table 71. BioMérieux Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 72. BioMérieux Defibrinated Horse Blood Product Portfolio Table 73. BioMérieux Recent Development Table 74. E & O Laboratories Ltd Company Information Table 75. E & O Laboratories Ltd Business Overview Table 76. E & O Laboratories Ltd Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 77. E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio Table 78. E & O Laboratories Ltd Recent Development Table 79. Southern Biological Company Information Table 80. Southern Biological Business Overview Table 81. Southern Biological Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 82. Southern Biological Defibrinated Horse Blood Product Portfolio Table 83. Southern Biological Recent Development Table 84. Biowest(BioNordic A/S) Company Information Table 85. Biowest(BioNordic A/S) Business Overview Table 86. Biowest(BioNordic A/S) Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 87. Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio Table 88. Biowest(BioNordic A/S) Recent Development Table 89. Pel-Freez Biologicals Company Information Table 90. Pel-Freez Biologicals Business Overview Table 91. Pel-Freez Biologicals Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 92. Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio Table 93. Pel-Freez Biologicals Recent Development Table 94. Trafalgar Scientific Company Information Table 95. Trafalgar Scientific Business Overview Table 96. Trafalgar Scientific Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 97. Trafalgar Scientific Defibrinated Horse Blood Product Portfolio Table 98. Trafalgar Scientific Recent Development Table 99. HemoStat Laboratories Company Information Table 100. HemoStat Laboratories Business Overview Table 101. HemoStat Laboratories Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 102. HemoStat Laboratories Defibrinated Horse Blood Product Portfolio Table 103. HemoStat Laboratories Recent Development Table 104. EWC Diagnostics Company Information Table 105. EWC Diagnostics Business Overview Table 106. EWC Diagnostics Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 107. EWC Diagnostics Defibrinated Horse Blood Product Portfolio Table 108. EWC Diagnostics Recent Development Table 109. Dutscher Company Information Table 110. Dutscher Business Overview Table 111. Dutscher Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 112. Dutscher Defibrinated Horse Blood Product Portfolio Table 113. Dutscher Recent Development Table 114. Serana Europe Company Information Table 115. Serana Europe Business Overview Table 116. Serana Europe Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 117. Serana Europe Defibrinated Horse Blood Product Portfolio Table 118. Serana Europe Recent Development Table 119. Kraeber & Co. GmbH Company Information Table 120. Kraeber & Co. GmbH Business Overview Table 121. Kraeber & Co. GmbH Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 122. Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio Table 123. Kraeber & Co. GmbH Recent Development Table 124. Bio Nutrientes Do Brasil Ltda. Company Information Table 125. Bio Nutrientes Do Brasil Ltda. Business Overview Table 126. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 127. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio Table 128. Bio Nutrientes Do Brasil Ltda. Recent Development Table 129. Lampire Biological Laboratories, Inc. Company Information Table 130. Lampire Biological Laboratories, Inc. Business Overview Table 131. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 132. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio Table 133. Lampire Biological Laboratories, Inc. Recent Development Table 134. Innovative Research Inc Company Information Table 135. Innovative Research Inc Business Overview Table 136. Innovative Research Inc Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 137. Innovative Research Inc Defibrinated Horse Blood Product Portfolio Table 138. Innovative Research Inc Recent Development Table 139. Colorado Serum Company Information Table 140. Colorado Serum Business Overview Table 141. Colorado Serum Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 142. Colorado Serum Defibrinated Horse Blood Product Portfolio Table 143. Colorado Serum Recent Development Table 144. SSI Diagnostica Company Information Table 145. SSI Diagnostica Business Overview Table 146. SSI Diagnostica Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 147. SSI Diagnostica Defibrinated Horse Blood Product Portfolio Table 148. SSI Diagnostica Recent Development Table 149. SR Group Company Information Table 150. SR Group Business Overview Table 151. SR Group Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 152. SR Group Defibrinated Horse Blood Product Portfolio Table 153. SR Group Recent Development Table 154. Szabo-Scandic Company Information Table 155. Szabo-Scandic Business Overview Table 156. Szabo-Scandic Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 157. Szabo-Scandic Defibrinated Horse Blood Product Portfolio Table 158. Szabo-Scandic Recent Development Table 159. Rockland Immunochemicals, Inc. Company Information Table 160. Rockland Immunochemicals, Inc. Business Overview Table 161. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 162. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio Table 163. Rockland Immunochemicals, Inc. Recent Development Table 164. LABone Scientific Co.Ltd. Company Information Table 165. LABone Scientific Co.Ltd. Business Overview Table 166. LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 167. LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio Table 168. LABone Scientific Co.Ltd. Recent Development Table 169. Quad Five(Materials Bio Inc.) Company Information Table 170. Quad Five(Materials Bio Inc.) Business Overview Table 171. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 172. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio Table 173. Quad Five(Materials Bio Inc.) Recent Development Table 174. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 175. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 176. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 177. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 178. Guangzhou Ruite Biotechnology Co., Ltd. Recent Development Table 179. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 180. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 181. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 182. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio Table 183. Obio Technology (Shanghai) Corp., Ltd. Recent Development Table 184. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 185. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 186. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 187. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio Table 188. Beijing Solarbio Science & Technology Co.,Ltd. Recent Development Table 189. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 190. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 191. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 192. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 193. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Development Table 194. North America Defibrinated Horse Blood Revenue by Type (2021-2026) & (US$ Million) Table 195. North America Defibrinated Horse Blood Revenue by Type (2027-2032) & (US$ Million) Table 196. North America Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 197. North America Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 198. North America Defibrinated Horse Blood Sales Price by Type (2021-2026) & (USD/L) Table 199. North America Defibrinated Horse Blood Sales Price by Type (2027-2032) & (USD/L) Table 200. North America Defibrinated Horse Blood Revenue by Application (2021-2026) & (US$ Million) Table 201. North America Defibrinated Horse Blood Revenue by Application (2027-2032) & (US$ Million) Table 202. North America Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 203. North America Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 204. North America Defibrinated Horse Blood Sales Price by Application (2021-2026) & (USD/L) Table 205. North America Defibrinated Horse Blood Sales Price by Application (2027-2032) & (USD/L) Table 206. North America Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. North America Defibrinated Horse Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. North America Defibrinated Horse Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. North America Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 210. North America Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 211. North America Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 212. North America Defibrinated Horse Blood Sales Price by Country (2021-2026) & (USD/L) Table 213. North America Defibrinated Horse Blood Sales Price by Country (2027-2032) & (USD/L) Table 214. United States Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 215. Canada Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 216. Mexico Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 217. Europe Defibrinated Horse Blood Revenue by Type (2021-2026) & (US$ Million) Table 218. Europe Defibrinated Horse Blood Revenue by Type (2027-2032) & (US$ Million) Table 219. Europe Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 220. Europe Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 221. Europe Defibrinated Horse Blood Sales Price by Type (2021-2026) & (USD/L) Table 222. Europe Defibrinated Horse Blood Sales Price by Type (2027-2032) & (USD/L) Table 223. Europe Defibrinated Horse Blood Revenue by Application (2021-2026) & (US$ Million) Table 224. Europe Defibrinated Horse Blood Revenue by Application (2027-2032) & (US$ Million) Table 225. Europe Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 226. Europe Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 227. Europe Defibrinated Horse Blood Sales Price by Application (2021-2026) & (USD/L) Table 228. Europe Defibrinated Horse Blood Sales Price by Application (2027-2032) & (USD/L) Table 229. Europe Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. Europe Defibrinated Horse Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. Europe Defibrinated Horse Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. Europe Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 233. Europe Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 234. Europe Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 235. Europe Defibrinated Horse Blood Sales Price by Country (2021-2026) & (USD/L) Table 236. Europe Defibrinated Horse Blood Sales Price by Country (2027-2032) & (USD/L) Table 237. Germany Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 238. France Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 239. U.K. Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 240. Italy Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 241. Russia Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 242. Spain Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 243. Netherlands Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 244. Switzerland Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 245. Sweden Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 246. Poland Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 247. China Defibrinated Horse Blood Revenue by Type (2021-2026) & (US$ Million) Table 248. China Defibrinated Horse Blood Revenue by Type (2027-2032) & (US$ Million) Table 249. China Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 250. China Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 251. China Defibrinated Horse Blood Sales Price by Type (2021-2026) & (USD/L) Table 252. China Defibrinated Horse Blood Sales Price by Type (2027-2032) & (USD/L) Table 253. China Defibrinated Horse Blood Revenue by Application (2021-2026) & (US$ Million) Table 254. China Defibrinated Horse Blood Revenue by Application (2027-2032) & (US$ Million) Table 255. China Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 256. China Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 257. China Defibrinated Horse Blood Sales Price by Application (2021-2026) & (USD/L) Table 258. China Defibrinated Horse Blood Sales Price by Application (2027-2032) & (USD/L) Table 259. Asia Defibrinated Horse Blood Revenue by Type (2021-2026) & (US$ Million) Table 260. Asia Defibrinated Horse Blood Revenue by Type (2027-2032) & (US$ Million) Table 261. Asia Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 262. Asia Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 263. Asia Defibrinated Horse Blood Sales Price by Type (2021-2026) & (USD/L) Table 264. Asia Defibrinated Horse Blood Sales Price by Type (2027-2032) & (USD/L) Table 265. Asia Defibrinated Horse Blood Revenue by Application (2021-2026) & (US$ Million) Table 266. Asia Defibrinated Horse Blood Revenue by Application (2027-2032) & (US$ Million) Table 267. Asia Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 268. Asia Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 269. Asia Defibrinated Horse Blood Sales Price by Application (2021-2026) & (USD/L) Table 270. Asia Defibrinated Horse Blood Sales Price by Application (2027-2032) & (USD/L) Table 271. Asia Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 272. Asia Defibrinated Horse Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 273. Asia Defibrinated Horse Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 274. Asia Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 275. Asia Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 276. Asia Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 277. Asia Defibrinated Horse Blood Sales Price by Country (2021-2026) & (USD/L) Table 278. Asia Defibrinated Horse Blood Sales Price by Country (2027-2032) & (USD/L) Table 279. Japan Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 280. South Korea Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 281. India Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 282. Australia Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 283. Taiwan Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 284. Southeast Asia Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 285. SAMEA Defibrinated Horse Blood Revenue by Type (2021-2026) & (US$ Million) Table 286. SAMEA Defibrinated Horse Blood Revenue by Type (2027-2032) & (US$ Million) Table 287. SAMEA Defibrinated Horse Blood Sales by Type (2021-2026) & (kL) Table 288. SAMEA Defibrinated Horse Blood Sales by Type (2027-2032) & (kL) Table 289. SAMEA Defibrinated Horse Blood Sales Price by Type (2021-2026) & (USD/L) Table 290. SAMEA Defibrinated Horse Blood Sales Price by Type (2027-2032) & (USD/L) Table 291. SAMEA Defibrinated Horse Blood Revenue by Application (2021-2026) & (US$ Million) Table 292. SAMEA Defibrinated Horse Blood Revenue by Application (2027-2032) & (US$ Million) Table 293. SAMEA Defibrinated Horse Blood Sales by Application (2021-2026) & (kL) Table 294. SAMEA Defibrinated Horse Blood Sales by Application (2027-2032) & (kL) Table 295. SAMEA Defibrinated Horse Blood Sales Price by Application (2021-2026) & (USD/L) Table 296. SAMEA Defibrinated Horse Blood Sales Price by Application (2027-2032) & (USD/L) Table 297. SAMEA Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 298. SAMEA Defibrinated Horse Blood Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 299. SAMEA Defibrinated Horse Blood Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 300. SAMEA Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032) & (kL) Table 301. SAMEA Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 302. SAMEA Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 303. SAMEA Defibrinated Horse Blood Sales Price by Country (2021-2026) & (USD/L) Table 304. SAMEA Defibrinated Horse Blood Sales Price by Country (2027-2032) & (USD/L) Table 305. Brazil Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 306. Argentina Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 307. Chile Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 308. Colombia Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 309. Peru Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 310. Saudi Arabia Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 311. Israel Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 312. UAE Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 313. Turkey Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 314. Iran Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 315. Egypt Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Table 316. Key Raw Materials Table 317. Raw Materials Key Suppliers Table 318. Defibrinated Horse Blood Distributors List Table 319. Defibrinated Horse Blood Customers List Table 320. Research Programs/Design for This Report Table 321. Authors List of This Report Table 322. Secondary Sources Table 323. Primary Sources List of Figures Figure 1. Defibrinated Horse Blood Image Figure 2. Global Defibrinated Horse Blood Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Defibrinated Horse Blood Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50ml Image Figure 5. 100ml Image Figure 6. 250ml Image Figure 7. 500ml Image Figure 8. Others Image Figure 9. Global Defibrinated Horse Blood Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Defibrinated Horse Blood Market Size Share 2021 VS 2025 VS 2032 Figure 11. Biomedicine Image Figure 12. Research Image Figure 13. Global Defibrinated Horse Blood Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Defibrinated Horse Blood Revenue (2021-2032) & (US$ Million) Figure 15. Global Defibrinated Horse Blood Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Defibrinated Horse Blood Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Defibrinated Horse Blood Revenue Market Share by Region (2021-2032) Figure 18. Global Defibrinated Horse Blood Sales (2021-2032) & (kL) Figure 19. Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032 (kL) Figure 20. Global Defibrinated Horse Blood Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Defibrinated Horse Blood Sales YoY (2021-2032) & (kL) Figure 22. Europe Defibrinated Horse Blood Sales YoY (2021-2032) & (kL) Figure 23. China Defibrinated Horse Blood Sales YoY (2021-2032) & (kL) Figure 24. Asia (Excluding China) Defibrinated Horse Blood Sales YoY (2021-2032) & (kL) Figure 25. South America, Middle East and Africa Defibrinated Horse Blood Sales YoY (2021-2032) & (kL) Figure 26. Global Defibrinated Horse Blood Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Defibrinated Horse Blood Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Defibrinated Horse Blood Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Defibrinated Horse Blood Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Defibrinated Horse Blood Revenue Market Share by Type (2021-2032) Figure 32. Global Defibrinated Horse Blood Sales by Type (2021 VS 2025 VS 2032) & (kL) Figure 33. Global Defibrinated Horse Blood Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Defibrinated Horse Blood Sales Market Share by Type (2021-2032) Figure 35. Global Defibrinated Horse Blood Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Defibrinated Horse Blood Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Defibrinated Horse Blood Revenue Market Share by Application (2021-2032) Figure 38. Global Defibrinated Horse Blood Sales by Application (2021 VS 2025 VS 2032) & (kL) Figure 39. Global Defibrinated Horse Blood Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Defibrinated Horse Blood Sales Market Share by Application (2021-2032) Figure 41. North America Defibrinated Horse Blood Revenue Share by Type (2021-2032) Figure 42. North America Defibrinated Horse Blood Sales Share by Type (2021-2032) Figure 43. North America Defibrinated Horse Blood Revenue Share by Application (2021-2032) Figure 44. North America Defibrinated Horse Blood Sales Share by Application (2021-2032) Figure 45. North America Defibrinated Horse Blood Revenue Share by Country (2021-2032) Figure 46. North America Defibrinated Horse Blood Sales Share by Country (2021-2032) Figure 47. Europe Defibrinated Horse Blood Revenue Share by Type (2021-2032) Figure 48. Europe Defibrinated Horse Blood Sales Share by Type (2021-2032) Figure 49. Europe Defibrinated Horse Blood Revenue Share by Application (2021-2032) Figure 50. Europe Defibrinated Horse Blood Sales Share by Application (2021-2032) Figure 51. Europe Defibrinated Horse Blood Revenue Share by Country (2021-2032) Figure 52. Europe Defibrinated Horse Blood Sales Share by Country (2021-2032) Figure 53. China Defibrinated Horse Blood Revenue Share by Type (2021-2032) Figure 54. China Defibrinated Horse Blood Sales Share by Type (2021-2032) Figure 55. China Defibrinated Horse Blood Revenue Share by Application (2021-2032) Figure 56. China Defibrinated Horse Blood Sales Share by Application (2021-2032) Figure 57. Asia Defibrinated Horse Blood Revenue Share by Type (2021-2032) Figure 58. Asia Defibrinated Horse Blood Sales Share by Type (2021-2032) Figure 59. Asia Defibrinated Horse Blood Revenue Share by Application (2021-2032) Figure 60. Asia Defibrinated Horse Blood Sales Share by Application (2021-2032) Figure 61. Asia Defibrinated Horse Blood Revenue Share by Country (2021-2032) Figure 62. Asia Defibrinated Horse Blood Sales Share by Country (2021-2032) Figure 63. SAMEA Defibrinated Horse Blood Revenue Share by Type (2021-2032) Figure 64. SAMEA Defibrinated Horse Blood Sales Share by Type (2021-2032) Figure 65. SAMEA Defibrinated Horse Blood Revenue Share by Application

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 250ml
  • 500ml
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • Trafalgar Scientific
  • HemoStat Laboratories
  • EWC Diagnostics
  • Dutscher
  • Serana Europe
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Defibrinated Horse Blood Market by Type
  3. 1.2.1 Global Defibrinated Horse Blood Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50ml
  5. 1.2.3 100ml
  6. 1.2.4 250ml
  7. 1.2.5 500ml
  8. 1.2.6 Others
  9. 1.3 Defibrinated Horse Blood Market by Application
  10. 1.3.1 Global Defibrinated Horse Blood Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Biomedicine
  12. 1.3.3 Research
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Defibrinated Horse Blood Market Dynamics
  1. 2.1 Defibrinated Horse Blood Industry Trends
  2. 2.2 Defibrinated Horse Blood Industry Drivers
  3. 2.3 Defibrinated Horse Blood Industry Opportunities and Challenges
  4. 2.4 Defibrinated Horse Blood Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Defibrinated Horse Blood Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Defibrinated Horse Blood Revenue by Region
  3. 3.2.1 Global Defibrinated Horse Blood Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Defibrinated Horse Blood Revenue by Region (2021-2026)
  5. 3.2.3 Global Defibrinated Horse Blood Revenue by Region (2027-2032)
  6. 3.2.4 Global Defibrinated Horse Blood Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Defibrinated Horse Blood Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Defibrinated Horse Blood Sales by Region
  9. 3.4.1 Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Defibrinated Horse Blood Sales by Region (2021-2026)
  11. 3.4.3 Global Defibrinated Horse Blood Sales by Region (2027-2032)
  12. 3.4.4 Global Defibrinated Horse Blood Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Defibrinated Horse Blood Revenue by Manufacturers
  2. 4.1.1 Global Defibrinated Horse Blood Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Defibrinated Horse Blood Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Defibrinated Horse Blood Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Defibrinated Horse Blood Sales by Manufacturers
  6. 4.2.1 Global Defibrinated Horse Blood Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Defibrinated Horse Blood Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Defibrinated Horse Blood Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Defibrinated Horse Blood Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Defibrinated Horse Blood Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Defibrinated Horse Blood Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Defibrinated Horse Blood Manufacturers, Product Type & Application
  13. 4.7 Global Defibrinated Horse Blood Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Defibrinated Horse Blood Market CR5 and HHI
  16. 4.8.2 2025 Defibrinated Horse Blood Tier 1, Tier 2, and Tier 3
5 Defibrinated Horse Blood Market by Type
  1. 5.1 Global Defibrinated Horse Blood Revenue by Type
  2. 5.1.1 Global Defibrinated Horse Blood Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Defibrinated Horse Blood Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Defibrinated Horse Blood Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Defibrinated Horse Blood Sales by Type
  6. 5.2.1 Global Defibrinated Horse Blood Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Defibrinated Horse Blood Sales by Type (2021-2032) & (kL)
  8. 5.2.3 Global Defibrinated Horse Blood Sales Market Share by Type (2021-2032)
  9. 5.3 Global Defibrinated Horse Blood Price by Type
6 Defibrinated Horse Blood Market by Application
  1. 6.1 Global Defibrinated Horse Blood Revenue by Application
  2. 6.1.1 Global Defibrinated Horse Blood Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Defibrinated Horse Blood Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Defibrinated Horse Blood Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Defibrinated Horse Blood Sales by Application
  6. 6.2.1 Global Defibrinated Horse Blood Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Defibrinated Horse Blood Sales by Application (2021-2032) & (kL)
  8. 6.2.3 Global Defibrinated Horse Blood Sales Market Share by Application (2021-2032)
  9. 6.3 Global Defibrinated Horse Blood Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 TCS Biosciences
  8. 7.2.1 TCS Biosciences Company Information
  9. 7.2.2 TCS Biosciences Business Overview
  10. 7.2.3 TCS Biosciences Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TCS Biosciences Defibrinated Horse Blood Product Portfolio
  12. 7.2.5 TCS Biosciences Recent Developments
  13. 7.3 BioMérieux
  14. 7.3.1 BioMérieux Company Information
  15. 7.3.2 BioMérieux Business Overview
  16. 7.3.3 BioMérieux Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BioMérieux Defibrinated Horse Blood Product Portfolio
  18. 7.3.5 BioMérieux Recent Developments
  19. 7.4 E & O Laboratories Ltd
  20. 7.4.1 E & O Laboratories Ltd Company Information
  21. 7.4.2 E & O Laboratories Ltd Business Overview
  22. 7.4.3 E & O Laboratories Ltd Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio
  24. 7.4.5 E & O Laboratories Ltd Recent Developments
  25. 7.5 Southern Biological
  26. 7.5.1 Southern Biological Company Information
  27. 7.5.2 Southern Biological Business Overview
  28. 7.5.3 Southern Biological Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Southern Biological Defibrinated Horse Blood Product Portfolio
  30. 7.5.5 Southern Biological Recent Developments
  31. 7.6 Biowest(BioNordic A/S)
  32. 7.6.1 Biowest(BioNordic A/S) Company Information
  33. 7.6.2 Biowest(BioNordic A/S) Business Overview
  34. 7.6.3 Biowest(BioNordic A/S) Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio
  36. 7.6.5 Biowest(BioNordic A/S) Recent Developments
  37. 7.7 Pel-Freez Biologicals
  38. 7.7.1 Pel-Freez Biologicals Company Information
  39. 7.7.2 Pel-Freez Biologicals Business Overview
  40. 7.7.3 Pel-Freez Biologicals Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio
  42. 7.7.5 Pel-Freez Biologicals Recent Developments
  43. 7.8 Trafalgar Scientific
  44. 7.8.1 Trafalgar Scientific Company Information
  45. 7.8.2 Trafalgar Scientific Business Overview
  46. 7.8.3 Trafalgar Scientific Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Trafalgar Scientific Defibrinated Horse Blood Product Portfolio
  48. 7.8.5 Trafalgar Scientific Recent Developments
  49. 7.9 HemoStat Laboratories
  50. 7.9.1 HemoStat Laboratories Company Information
  51. 7.9.2 HemoStat Laboratories Business Overview
  52. 7.9.3 HemoStat Laboratories Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 HemoStat Laboratories Defibrinated Horse Blood Product Portfolio
  54. 7.9.5 HemoStat Laboratories Recent Developments
  55. 7.10 EWC Diagnostics
  56. 7.10.1 EWC Diagnostics Company Information
  57. 7.10.2 EWC Diagnostics Business Overview
  58. 7.10.3 EWC Diagnostics Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 EWC Diagnostics Defibrinated Horse Blood Product Portfolio
  60. 7.10.5 EWC Diagnostics Recent Developments
  61. 7.11 Dutscher
  62. 7.11.1 Dutscher Company Information
  63. 7.11.2 Dutscher Business Overview
  64. 7.11.3 Dutscher Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Dutscher Defibrinated Horse Blood Product Portfolio
  66. 7.11.5 Dutscher Recent Developments
  67. 7.12 Serana Europe
  68. 7.12.1 Serana Europe Company Information
  69. 7.12.2 Serana Europe Business Overview
  70. 7.12.3 Serana Europe Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Serana Europe Defibrinated Horse Blood Product Portfolio
  72. 7.12.5 Serana Europe Recent Developments
  73. 7.13 Kraeber & Co. GmbH
  74. 7.13.1 Kraeber & Co. GmbH Company Information
  75. 7.13.2 Kraeber & Co. GmbH Business Overview
  76. 7.13.3 Kraeber & Co. GmbH Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio
  78. 7.13.5 Kraeber & Co. GmbH Recent Developments
  79. 7.14 Bio Nutrientes Do Brasil Ltda.
  80. 7.14.1 Bio Nutrientes Do Brasil Ltda. Company Information
  81. 7.14.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  82. 7.14.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio
  84. 7.14.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  85. 7.15 Lampire Biological Laboratories, Inc.
  86. 7.15.1 Lampire Biological Laboratories, Inc. Company Information
  87. 7.15.2 Lampire Biological Laboratories, Inc. Business Overview
  88. 7.15.3 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio
  90. 7.15.5 Lampire Biological Laboratories, Inc. Recent Developments
  91. 7.16 Innovative Research Inc
  92. 7.16.1 Innovative Research Inc Company Information
  93. 7.16.2 Innovative Research Inc Business Overview
  94. 7.16.3 Innovative Research Inc Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Innovative Research Inc Defibrinated Horse Blood Product Portfolio
  96. 7.16.5 Innovative Research Inc Recent Developments
  97. 7.17 Colorado Serum
  98. 7.17.1 Colorado Serum Company Information
  99. 7.17.2 Colorado Serum Business Overview
  100. 7.17.3 Colorado Serum Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Colorado Serum Defibrinated Horse Blood Product Portfolio
  102. 7.17.5 Colorado Serum Recent Developments
  103. 7.18 SSI Diagnostica
  104. 7.18.1 SSI Diagnostica Company Information
  105. 7.18.2 SSI Diagnostica Business Overview
  106. 7.18.3 SSI Diagnostica Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 SSI Diagnostica Defibrinated Horse Blood Product Portfolio
  108. 7.18.5 SSI Diagnostica Recent Developments
  109. 7.19 SR Group
  110. 7.19.1 SR Group Company Information
  111. 7.19.2 SR Group Business Overview
  112. 7.19.3 SR Group Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 SR Group Defibrinated Horse Blood Product Portfolio
  114. 7.19.5 SR Group Recent Developments
  115. 7.20 Szabo-Scandic
  116. 7.20.1 Szabo-Scandic Company Information
  117. 7.20.2 Szabo-Scandic Business Overview
  118. 7.20.3 Szabo-Scandic Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Szabo-Scandic Defibrinated Horse Blood Product Portfolio
  120. 7.20.5 Szabo-Scandic Recent Developments
  121. 7.21 Rockland Immunochemicals, Inc.
  122. 7.21.1 Rockland Immunochemicals, Inc. Company Information
  123. 7.21.2 Rockland Immunochemicals, Inc. Business Overview
  124. 7.21.3 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio
  126. 7.21.5 Rockland Immunochemicals, Inc. Recent Developments
  127. 7.22 LABone Scientific Co.Ltd.
  128. 7.22.1 LABone Scientific Co.Ltd. Company Information
  129. 7.22.2 LABone Scientific Co.Ltd. Business Overview
  130. 7.22.3 LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio
  132. 7.22.5 LABone Scientific Co.Ltd. Recent Developments
  133. 7.23 Quad Five(Materials Bio Inc.)
  134. 7.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 7.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 7.23.3 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio
  138. 7.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 7.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 7.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 7.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 7.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  144. 7.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 7.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 7.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 7.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 7.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio
  150. 7.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 7.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 7.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 7.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 7.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio
  156. 7.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 7.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 7.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 7.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 7.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  162. 7.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Defibrinated Horse Blood Market Size by Type
  2. 8.1.1 North America Defibrinated Horse Blood Revenue by Type (2021-2032)
  3. 8.1.2 North America Defibrinated Horse Blood Sales by Type (2021-2032)
  4. 8.1.3 North America Defibrinated Horse Blood Price by Type (2021-2032)
  5. 8.2 North America Defibrinated Horse Blood Market Size by Application
  6. 8.2.1 North America Defibrinated Horse Blood Revenue by Application (2021-2032)
  7. 8.2.2 North America Defibrinated Horse Blood Sales by Application (2021-2032)
  8. 8.2.3 North America Defibrinated Horse Blood Price by Application (2021-2032)
  9. 8.3 North America Defibrinated Horse Blood Market Size by Country
  10. 8.3.1 North America Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Defibrinated Horse Blood Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Defibrinated Horse Blood Market Size by Type
  2. 9.1.1 Europe Defibrinated Horse Blood Revenue by Type (2021-2032)
  3. 9.1.2 Europe Defibrinated Horse Blood Sales by Type (2021-2032)
  4. 9.1.3 Europe Defibrinated Horse Blood Price by Type (2021-2032)
  5. 9.2 Europe Defibrinated Horse Blood Market Size by Application
  6. 9.2.1 Europe Defibrinated Horse Blood Revenue by Application (2021-2032)
  7. 9.2.2 Europe Defibrinated Horse Blood Sales by Application (2021-2032)
  8. 9.2.3 Europe Defibrinated Horse Blood Price by Application (2021-2032)
  9. 9.3 Europe Defibrinated Horse Blood Market Size by Country
  10. 9.3.1 Europe Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Defibrinated Horse Blood Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Defibrinated Horse Blood Market Size by Type
  2. 10.1.1 China Defibrinated Horse Blood Revenue by Type (2021-2032)
  3. 10.1.2 China Defibrinated Horse Blood Sales by Type (2021-2032)
  4. 10.1.3 China Defibrinated Horse Blood Price by Type (2021-2032)
  5. 10.2 China Defibrinated Horse Blood Market Size by Application
  6. 10.2.1 China Defibrinated Horse Blood Revenue by Application (2021-2032)
  7. 10.2.2 China Defibrinated Horse Blood Sales by Application (2021-2032)
  8. 10.2.3 China Defibrinated Horse Blood Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Defibrinated Horse Blood Market Size by Type
  2. 11.1.1 Asia Defibrinated Horse Blood Revenue by Type (2021-2032)
  3. 11.1.2 Asia Defibrinated Horse Blood Sales by Type (2021-2032)
  4. 11.1.3 Asia Defibrinated Horse Blood Price by Type (2021-2032)
  5. 11.2 Asia Defibrinated Horse Blood Market Size by Application
  6. 11.2.1 Asia Defibrinated Horse Blood Revenue by Application (2021-2032)
  7. 11.2.2 Asia Defibrinated Horse Blood Sales by Application (2021-2032)
  8. 11.2.3 Asia Defibrinated Horse Blood Price by Application (2021-2032)
  9. 11.3 Asia Defibrinated Horse Blood Market Size by Country
  10. 11.3.1 Asia Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Defibrinated Horse Blood Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Defibrinated Horse Blood Market Size by Type
  2. 12.1.1 SAMEA Defibrinated Horse Blood Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Defibrinated Horse Blood Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Defibrinated Horse Blood Price by Type (2021-2032)
  5. 12.2 SAMEA Defibrinated Horse Blood Market Size by Application
  6. 12.2.1 SAMEA Defibrinated Horse Blood Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Defibrinated Horse Blood Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Defibrinated Horse Blood Price by Application (2021-2032)
  9. 12.3 SAMEA Defibrinated Horse Blood Market Size by Country
  10. 12.3.1 SAMEA Defibrinated Horse Blood Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Defibrinated Horse Blood Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Defibrinated Horse Blood Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Defibrinated Horse Blood Value Chain Analysis
  2. 13.1.1 Defibrinated Horse Blood Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Defibrinated Horse Blood Production Mode & Process
  6. 13.2 Defibrinated Horse Blood Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Defibrinated Horse Blood Distributors
  9. 13.2.3 Defibrinated Horse Blood Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research